NCT02635724 - Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

September 30, 2018

Conditions

Influenza

Interventions

DRUG

Peramivir

Trial Locations (15)

Peramivir Investigational Site, Brooksville

Peramivir Investigational Site, Lakeland

Peramivir Investigational Site, Miami

Peramivir Investigational Site, St. Petersburg

Peramivir Investigational Site, Tampa

Peramivir investigative site, Indianapolis

Peramivir investigative site, Detroit

Peramivir Investigational Site, Dayton

Peramivir investigative site, Smithfield

Peramivir Investigational Site, Houston

Peramivir Investigative Site, San Antonio

Peramivir investigative site, Splendora

Peramivir Investigational Site, Draper

Peramivir Investigational Site, Salt Lake City

Peramivir investigative site, South Jordan